Serono Upset At Generic Pergonal

Serono Laboratories is challenging a US Food and DrugAdministration decision to clear Ferring's generic urine-based menotropins infertility product without the required testing. Serono claims that the agency approved the generic product while considering Serono's "innovator" drug, the injectable infertility hormone Pergonal (menotropin for injection), "even though the agency acknowledged in previous documents that the active and inactive ingredients in Pergonal are different" from Ferring's product. Serono believes that this action was a violation of the law.